
Gastric bypass at MedProper Istanbul from £2,695 all-inclusive. Roux-en-Y and mini bypass. JCI hospital, IFSO surgeons, 12-month aftercare.
Безопасно ли е?
Вашата болница притежава същата JCI акредитация като Кливланд Клиник и Джонс Хопкинс. Верифицирана от TEMOS за безопасност на международни пациенти.
Ще се промени ли цената?
Цената ви е фиксирана преди да резервирате. Операция, болница, хотел, трансфери, следоперативни грижи — едно число, без допълнителни разходи.
Какво ако нещо се обърка?
Задължителна застраховка, изисквана от турското законодателство. Ако е необходима ревизия — полети, болница, хирург — покрити. Никога не плащате два пъти.
Кой е моят хирург?
Потвърден преди да платите. Пълни квалификации, специализация и резултати на пациенти — споделени предварително. Без замяна в последния момент.
Какво става след като се прибера?
24/7 WhatsApp с вашия координатор. Планирани видео прегледи с вашия хирург. 12 месеца, не 12 дни.
Gastric bypass surgery, formally known as Roux-en-Y gastric bypass (RYGB), is the gold standard of metabolic surgery and one of the most thoroughly studied surgical procedures in medicine. During the operation, the surgeon creates a small stomach pouch of approximately 30 ml — roughly the size of an egg — and reroutes the small intestine to connect directly to this pouch, bypassing the majority of the stomach and the first section of the small intestine (the duodenum).
This dual mechanism — restriction (smaller stomach) plus controlled malabsorption (bypassed intestine) — produces greater average weight loss than gastric sleeve and the highest rates of Type 2 diabetes remission among all bariatric procedures. First performed in 1967 and performed laparoscopically since the mid-1990s, Roux-en-Y gastric bypass has the longest track record of any modern bariatric procedure.
At MedProper Istanbul, gastric bypass is performed laparoscopically through 5 small incisions by IFSO-member bariatric surgeons in a JCI-accredited hospital, with all-inclusive packages starting from £2,695 / €3,150.
| Procedure | MedProper (GBP) | MedProper (EUR) | UK Private | USA Private | You Save |
|---|---|---|---|---|---|
| Gastric Bypass (Roux-en-Y) | from £2,695 | from €3,150 | £8,000-£12,000 | $20,000-$35,000 |
Получете персонализиран план за лечение с прозрачни цени. Без скрити такси, без ангажимент.
| up to 90% |
| Mini Gastric Bypass (OAGB) | from £2,695 | from €3,150 | £8,000-£12,000 | $20,000-$35,000 | up to 90% |
| Cost Component | MedProper Istanbul | UK Private Clinic | USA Private Clinic |
|---|---|---|---|
| Surgeon fee | Included | £4,000-£6,000 | $10,000-$18,000 |
| Operating facility + theatre | Included | £1,500-£2,500 | $3,000-£5,000 |
| Anaesthesia (general) | Included | £500-£1,000 | $1,000-$2,000 |
| Hospital stay (3-5 nights) | Included | £500-£1,000/night | $1,000-$2,000/night |
| Hotel (3-5 nights, 4-5 star) | Included | N/A | N/A |
| VIP airport transfers | Included | N/A | N/A |
| Pre-operative blood work + imaging | Included | £200-£400 | $500-$1,000 |
| Post-operative medications | Included | £50-£150 | $100-$300 |
| Vitamin supplements (3 months) | Included | £30-£60 | $50-$100 |
| Dietitian consultation | Included | £100-£250/visit | $200-$400/visit |
| Leak test (contrast swallow) | Included | Varies | Varies |
| 12-month aftercare | Included | £100-£250/visit | $200-$400/visit |
| Total | from £2,695 | £7,500-£13,000+ | $16,000-$30,000+ |
The classic gastric bypass technique, performed since 1967. The surgeon creates two anastomoses (connections): one between the small stomach pouch and the Roux limb of the jejunum (~150 cm), and a second Y-connection where the biliopancreatic limb rejoins. This creates separate pathways for food and digestive enzymes, combining restriction with controlled malabsorption.
A simplified version of Roux-en-Y with a single intestinal connection instead of two. Creates a longer, tubular stomach pouch connected to a loop of small intestine approximately 200 cm from the ligament of Treitz. Now representing approximately 30% of all bypass procedures globally and growing in popularity.
This is the most common question patients ask. The answer depends on your BMI, health conditions, and specific goals:
| Criteria | Gastric Bypass (Roux-en-Y) | Gastric Sleeve |
|---|---|---|
| How it works | Small pouch (~30 ml) + intestine rerouted | 75-80% of stomach removed |
| Duration | 90-150 minutes | 45-75 minutes |
| Hospital stay | 3-5 nights | 2-4 nights |
| Weight loss (12-18 months) | 65-75% excess weight | 60-70% excess weight |
| Type 2 diabetes remission | 80%+ (superior) | ~60% |
| Acid reflux (GORD) | Resolves in 90%+ | May worsen (15-20%) |
| Dumping syndrome | 10-15% (discourages sugar) | Rare |
| Lifetime supplements | Required (B12, iron, calcium, multivitamin) | Recommended (multivitamin) |
| Reversibility | Technically reversible, rarely performed | Irreversible |
| MedProper price | from £2,695 | from £1,925 |
| Best for | BMI 45+, T2 diabetes, chronic GORD | BMI 35-45, no severe reflux |
MedProper recommendation: Gastric sleeve is optimal for most patients (BMI 35-45 without severe reflux) due to simpler surgery, faster recovery, and lower supplement requirements. Gastric bypass is specifically recommended when the patient has BMI over 45, poorly controlled Type 2 diabetes, chronic acid reflux, or a sweet-eating pattern (bypass creates dumping syndrome which discourages sugar consumption).
Gastric bypass is the recommended procedure when:
Total duration: 90-150 minutes. The procedure is performed entirely laparoscopically — no large incisions.
The mortality rate for laparoscopic Roux-en-Y gastric bypass at experienced, high-volume centres is approximately 0.2-0.5% — slightly higher than gastric sleeve (0.08-0.19%) due to the greater surgical complexity (two anastomoses versus none). At JCI-accredited hospitals with standardised protocols, the rate is at the lower end of this range.
For perspective: the long-term mortality risk of untreated severe obesity far exceeds the surgical risk. Bariatric surgery reduces all-cause mortality by 50-70% over 10 years (Lancet, 2024).
| Complication | Frequency | MedProper Management |
|---|---|---|
| Anastomotic leak | <2% | Dual leak test protocol |
| Internal hernia | 1-3% (long-term) | Mesenteric defect closure during surgery |
| Marginal ulcer | 5-10% | Treatable with PPI medication |
| Dumping syndrome | 10-15% | Dietary management (usually resolves) |
| Nutritional deficiency | Ongoing risk | Mandatory supplement protocol + monitoring |
| Bleeding | <1% | 24-hour monitoring + Level 3 ICU on-site |
| DVT/PE | <1% | Prophylactic DVT protocol |
| Phase | Timeline | What to Expect |
|---|---|---|
| Hospital | Days 1-4 | Clear liquids, mobilisation, leak test, pain management |
| Hotel recovery | Days 5-7 | Full liquids (protein shakes), rest, dietary guidance |
| Home: liquids | Weeks 1-2 | Protein shakes, smooth soups, 60g protein/day target |
| Pureed foods | Weeks 3-4 | Blended vegetables, hummus, scrambled egg |
| Soft foods | Weeks 5-6 | Soft fish, cottage cheese, mashed vegetables |
| Normal diet | Week 7+ | Small portions, protein first, chew thoroughly |
| Return to desk work | 2-3 weeks | Light activity, no heavy lifting |
| Return to exercise | 4-6 weeks | Walking from day 1, moderate exercise from week 4 |
| Full recovery | 6-8 weeks | All normal activities resumed |
After gastric bypass, you must take the following supplements for life:
MedProper provides 3 months of supplements and a detailed protocol for your GP. Blood work should be checked at 6 weeks, 3 months, 6 months, and annually thereafter.
| Factor | GLP-1 Medications (Ozempic/Wegovy) | Gastric Bypass |
|---|---|---|
| Weight loss | 15-20% of total body weight | 30-35% of total body weight |
| Type 2 diabetes | Improvement | 80%+ full remission |
| Duration | Must take indefinitely | One-time procedure |
| Monthly cost (UK) | £200-£300/month ongoing | One-time from £2,695 |
| 5-year cost (UK) | £12,000-£18,000 | £2,695 (one-time) |
| Weight regain on stopping | 60-70% within 12 months | 10-15% at 5 years |
| GORD effect | Neutral | Resolves 90%+ |
| Best for | BMI 27-35, medication-responsive | BMI 35+, lasting results, diabetes |
Surgery is more cost-effective, produces greater weight loss, superior diabetes remission, and does not require lifelong medication. Some patients use GLP-1 agonists as a bridge to surgery or as post-surgical support for stubborn plateaus.